Westfuller Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.6K Sell
117
-39
-25% -$5.92K ﹤0.01% 402
2026
Q2
$24.4K Hold
156
– – 0.01% 372
2026
Q1
$23.8K Sell
156
-1,472
-90% -$226K 0.01% 337
2025
Q4
$224K Hold
1,628
– – 0.09% 141
2025
Q3
$209K Buy
+1,628
New +$199K 0.09% 144

Other funds holding NVS

Westfuller Advisors's NVS Position: Q3 2026 in Review

Westfuller Advisors reduced its Novartis (NVS) stake by 25% in Q3 2026, selling an estimated $5.92K and leaving 117 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Westfuller Advisors first reported a position in NVS in Q3 2025 and has held it in 5 quarters since. The position peaked at $224K in Q4 2025. 1,548 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Westfuller Advisors held 117 shares of Novartis worth $16.6K as of Q3 2026.
  • Westfuller Advisors sold 39 Novartis shares in Q3 2026, an estimated $5.92K.
  • Novartis made up ﹤0.01% of Westfuller Advisors's portfolio in Q3 2026, its #402 holding.
  • Westfuller Advisors first reported a position in Novartis in Q3 2025 and has held it in 5 quarters since.
  • Westfuller Advisors's Novartis position peaked at $224K in Q4 2025.
  • 1,548 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Westfuller Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.